Characteristics of the study cohorts
| . | PF cohort (N = 37) . | Control cohort (N = 87) . |
|---|---|---|
| Sex (% male) | 59.5 | 70.1 |
| Mean age (±SD) | 44.5 ± 23.2 | 61.8 ± 17.2 |
| Race (% Caucasian) | 68.6 | 100% |
| Ventilated (%) | 80.0 | 81.6 |
| Mean platelet count (±SD) | 39.2 ± 35.2 | 203.4 ± 124.8 |
| Mean bilirubin (±SD) | 2.3 ± 2.4 | 1.3 ± 2.2 |
| Mean creatinine (±SD) | 3.6 ± 2.1 | 1.6 ± 1.1 |
| Mean lactate (±SD) | 9.0 ± 5.0 | UK |
| Mean protein C (% ± SD) | 22.8 ± 10.8 | UK |
| In-hospital mortality (%) | 42.4 | 21.8 |
| Mean SOFA score (± SD) | 12.8 ± 3.0 | 7.6 ± 2.8 |
| . | PF cohort (N = 37) . | Control cohort (N = 87) . |
|---|---|---|
| Sex (% male) | 59.5 | 70.1 |
| Mean age (±SD) | 44.5 ± 23.2 | 61.8 ± 17.2 |
| Race (% Caucasian) | 68.6 | 100% |
| Ventilated (%) | 80.0 | 81.6 |
| Mean platelet count (±SD) | 39.2 ± 35.2 | 203.4 ± 124.8 |
| Mean bilirubin (±SD) | 2.3 ± 2.4 | 1.3 ± 2.2 |
| Mean creatinine (±SD) | 3.6 ± 2.1 | 1.6 ± 1.1 |
| Mean lactate (±SD) | 9.0 ± 5.0 | UK |
| Mean protein C (% ± SD) | 22.8 ± 10.8 | UK |
| In-hospital mortality (%) | 42.4 | 21.8 |
| Mean SOFA score (± SD) | 12.8 ± 3.0 | 7.6 ± 2.8 |
Clinical and laboratory data at the time of presentation for patients in the Boston PF cohort (N = 37) and the NHLBI ARDSnet iSPAAR control cohort (N = 87).
SD, standard deviation; UK, unknown.